Single infection | Co-infection | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
 | Number | Rate (%) | Real-time PCR/RT-PCR results | Sequencing results | Measures of agreement Kappa values |  | Number | Rate (%) | Real-time PCR/RT-PCR results | Sequencing results | Measures of agreement Kappa values |
MDV | 26 | 8.7 % | 26 | 26 | 1 (p < 0.001) | MDV + ALV-A | 4 | 1.3 % | 4 | 4 | 1 (p < 0.001) |
ALV-A | 6 | 2.0 % | 6 | 6 | 1 (p < 0.001) | MDV + ALV-J | 25 | 8.3 % | 25 | 25 | 1 (p < 0.001) |
ALV-B | 2 | 0.7 % | 2 | 2 | 1 (p < 0.001) | ALV-B + ALV-J | 1 | 0.4 % | 1 | 1 | 1 (p < 0.001) |
ALV-J | 21 | 7.0 % | 21 | 21 | 1 (p < 0.001) | MDV + ALV-J + REV | 6 | 2 % | 6 | 6 | 1 (p < 0.001) |
REV | 15 | 5 % | 15 | 15 | 1 (p < 0.001) | MDV + CIAV | 5 | 1.6 % | 5 | 5 | 1 (p < 0.001) |
IBDV | 17 | 5.7 % | 17 | 17 | 1 (p < 0.001) | MDV + REV | 6 | 2 % | 6 | 6 | 1 (p < 0.001) |
CIAV | 9 | 3 % | 9 | 9 | 1 (p < 0.001) | ALV-J + REV | 3 | 1.5 % | 3 | 3 | 1 (p < 0.001) |
ARV | 23 | 7.7 % | 23 | 23 | 1 (p < 0.001) | IBDV + ALV-J | 5 | 1.6 % | 5 | 5 | 1 (p < 0.001) |
 |  |  |  |  |  | MDV + CIAV + ALV-J | 4 | 1.3 % | 4 | 4 | 1 (p < 0.001) |
 |  |  |  |  |  | REV + ARV | 3 | 1 % | 3 | 3 | 1 (p < 0.001) |
 |  |  |  |  |  | ALV-J + ARV | 6 | 2 % | 6 | 6 | 1 (p < 0.001) |
 |  |  |  |  |  | ALV-J + IBDV | 3 | 1 % | 3 | 3 | 1 (p < 0.001) |